GlassScriptPhysician profile
Katelyn M Gettel
NPI 1194210914
$6,734.47
in general payments reported to CMS, 2019-2025
15 companies · $2,561 in 2025
The $2,561 reported for 2025 was more than what 96% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $571 · 2022: $1,544 · 2023: $1,245 · 2024: $813 · 2025: $2,561.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,541 · Travel and Lodging: $1,078.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,541.08 |
| Travel and Lodging | $1,078.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,733.54 | 2021-2025 | Repatha, Repatha |
| Medtronic, INC. | $1,406.79 | 2025 | |
| Abbott Laboratories | $1,126.01 | 2022-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Aveir |
| Novartis Pharmaceuticals Corporation | $627.35 | 2021-2025 | |
| Pfizer INC. | $261.60 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $249.98 | 2021-2023 | Farxiga |
| Biosense Webster, INC. | $207.28 | 2023-2025 | Carto 3 |
| Novo Nordisk INC | $199.92 | 2021-2022 | |
| Esperion Therapeutics, INC. | $180.61 | 2021-2024 | Nexlizet, Nexletol |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $156.01 | 2023-2025 | Lifevest |
| Abbvie INC. | $132.33 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.99 | 2024 | Jardiance |
| Inspire Medical Systems, INC. | $124.99 | 2022 | |
| Boston Scientific Corporation | $121.95 | 2023-2025 | Watchman Flx |
| Janssen Pharmaceuticals, INC | $81.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katelyn Gettel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.